ArticlePloS one2025
Prevalence of peripheral arterial disease and arterial calcification based on three ankle-brachial index calculation methods (highest, average, and lowest systolic ankle pressure): A cross-sectional study in Type 2 diabetes mellitus patients in Peru.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeripheral arterial disease (PAD) and arterial calcification (AC) are frequent yet underdiagnosed vascular complications in individuals with type 2 diabetes mellitus (T2DM). The ankle-brachial index (ABI) is a widely used, non-invasive too for detecting these conditions. However, differences in ABI calculation methos can impact diagnostic accuracy and prevalence estimates.
objectiveTo determine the prevalence of PAD and AC based on three ABI calculation methods in patients with T2DM attending a public hospital in Peru. METHODOLOGY: We conducted a cross-sectional study using data from the At-Risk Foot Program of the Endocrinology Department at Hospital María Auxiliadora (2015-2020). ABI was calculated for each lower limb using the highest, average or lowest systolic ankle pressure (SAP) from either the dorsalis pedis or posterior tibial artery as the numerator, divided by the highest brachial systolic pressure as the denominator. We applied a hierarchical classification: PAD was identified first (ABI < 0.9 in either limb), and among those without PAD, AC was identified (ABI > 1.3 in either limb); the rest were classified as normal. Prevalences estimates were calculated with 95% confidence intervals, and associations with clinical characteristics were explored using Poisson regression with robust variance.
resultsWe included 643 subjects with a mean age of 61.4 years, 69.8% female. The prevalence of PAD was 7.8% (95% CI: 5.8-10.1), 15.4% (95% CI:12.7-18.4), and 28.2% (95% CI 24.7-31.7) using the highest, average, or lowest SAP as the numerator in the ABI, respectively. Conversely, the prevalence of AC was 18.2% (95% CI: 15.3-21.4), 11.0% (95% CI: 8.7-13.7), and 16.2% (95% CI:13.4-19.3). In all three methods, PAD was associated with older age (p < 0.05) and AC was associated with longer duration of diabetes (p < 0.01).
conclusionsAmong patients with T2DM, PAD prevalence varied substantially (7.8% - 28.2%) depending on the ABI calculation method, while AC was present in up to 18.2%. The lowest ankle pressure method increased sensitivity and may be preferred in high-risk populations where avoiding missed diagnoses is critical. The highest ankle pressure method, which maximizes specificity, may be more suitable for general screening and comparability with existing literature, whereas the average pressure approach could be useful in research or prognostic modeling. The hierarchical classification strategy allowed PAD and AC to coexist in the same individual, although this was rare. Given the variability in prevalence across methods, local validation studies are needed to determine which approach optimally balances sensitivity, specificity, and clinical applicability in Peruvian diabetic populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.